Elixxer

Elixxer P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of Elixxer (ELXR.H.V) as of Oct 16, 2026 is -0.19. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was -0.15 — a change of 25.94% (lower).

P/FCF

-0.19

YoY

25.94%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of Elixxer is 2023 -0.19 . P/FCF (Price-to-Free-Cash-Flow Ratio) of Elixxer was 2022 -0.15 . It decreases by 25.94% lower compared to the previous year.

The Elixxer P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2016
-0.10 CAD
Jan 1, 2017
-0.17 CAD
Jan 1, 2018
-0.10 CAD
Jan 1, 2019
-0.06 CAD
Jan 1, 2020
-0.15 CAD
Jan 1, 2021
-0.11 CAD
Jan 1, 2022
-0.15 CAD
Jan 1, 2023
-0.19 CAD
The Elixxer P/FCF history
YEARP/FCFYoY
-0.19+25.94%
-0.15+33.04%
-0.11-25.03%
-0.15+162.62%
-0.06-41.68%
-0.10-42.43%
-0.17+66.99%
-0.10-94.56%
-1.88-4.35%
-1.97—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Elixxer Stock analysis

What does Elixxer do? Elixxer Ltd, trading under the ticker ELXR.H.V and registered with ISIN CA28660W20004, is a company based in Montreal, Canada. It operates within the Financial Services sector, specifically in the Financials industry. The company completed its initial public offering on November 24, 2005. Elixxer Ltd maintains a website at https://www.elixxer.com/. The company's primary focus involves investments in cannabis-related businesses, including entities licensed for the cultivation, production, and sale of cannabis and cannabis-derived products. Its investment portfolio spans various segments of the cannabis industry, such as nutraceuticals, cosmetics, pharmaceuticals, cultivation, and extraction. The firm emphasizes medical cannabis and specialty cannabis-derived products within the pharmaceutical sector. Elixxer Ltd also engages in the cultivation and production of medical-grade cannabis for global markets. Additionally, the company develops and produces Cannabidiol (CBD) cosmetics and natural wellness products. It invests in facilities dedicated to the cultivation, extraction, and production of legal cannabis products. The company's brands include Viridi, Easyjoint, Freia, Little Green Pharma (LGP), and One Premium Cannabis. Elixxer Ltd holds investments in cannabis companies across multiple countries, including Australia, Canada, Switzerland, Italy, and Jamaica. Subsidiaries of the company include LGC Finance Limited, LGC Capital EU OU, and LGC Capital Spain S.L. Elixxer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Elixxer stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of Elixxer is -0.19 in 2023.

P/FCF (Price-to-Free-Cash-Flow Ratio) of Elixxer changed from -0.15 to -0.19, representing a 25.94% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) Elixxer since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s Elixxer with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Elixxer

All Key Metrics — Elixxer